Business Standard

Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks

After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100

pharmacy, drugs, medicine, pharma companies, pharmaceuticals
Premium

Avdhut Bagkar Mumbai
Led by gains in Divi's Labs, Sun Pharma, Cadila Healthcare and Dr Reddy's Laboratories, the Nifty Pharma pack was trading marginally higher in Wednesday's trade, with most stocks hovering near their all-time high levels.

Shares of Cipla hit a new all-time high of Rs 997 in Wednesday's session, looking poised to enter the four digit-share club after the Drugs Controller General of India (DCGI) permitted the firm to import Moderna's Covid Vaccine with emergency use authorisation in India. READ ABOUT IT HERE

Other pharma stocks like Divi's Laboratories and Dr Reddy were also trading near their all-time highs.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in